Recerca - El nostre equip

Marcela Villota-Rivas, MGH, is a public health systems research assistant, with a background in dietetics, for work focusing on non-communicable (metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH)) and communicable (viral hepatitis) liver disease. 

Línies de recerca

• MASLD/MASH
• Health systems
• Viral hepatitis
• Integrated care
• Stigma and discrimination

Publicacions principals

• Lazarus JV, Agirre-Garrido L, White TM, Arora AK, et al. Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study. Lancet Gastroenterol Hepatol, 2025. Doi: 10.1016/S2468-1253(25)00300-0
• Lazarus JV, Ivancovsky Wajcman D, Pannain S, Brennan PN, et al. The People-First Liver Charter. Nat Med, 2025. Doi: 10.1038/s41591-025-03759-8
• Díaz LA, Villota-Rivas M, Barrera F, Lazarus JV, et al. The burden of liver disease in Latin America. Ann Hepatol, 2023. Doi: 10.1016/j.aohep.2023.101175
• Lazarus JV, Mark HE, Allen AM, Arab JP, et al. A global action agenda for turning the tide on fatty liver disease. Hepatology, 2023. Doi: 10.1097/HEP.0000000000000545
• Rinella ME, Lazarus JV, Ratziu V, Francque SM, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 2023. Doi: 10.1097/HEP.0000000000000520
• Lazarus JV, Mark HE, Allen AM, Arab JP, et al. A global research priority agenda to advance public health responses to fatty liver disease. J Hepatol, 2023. Doi: 10.1016/j.jhep.2023.04.035